当前位置: X-MOL 学术Clin. Orthop. Relat. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Arthroscopic Partial Meniscectomy for a Degenerative Meniscus Tear Is Not Cost Effective Compared With Placebo Surgery: An Economic Evaluation Based on the FIDELITY Trial Data.
Clinical Orthopaedics and Related Research ( IF 4.2 ) Pub Date : 2024-05-07 , DOI: 10.1097/corr.0000000000003094
Roope Kalske, Ali Kiadaliri, Raine Sihvonen, Martin Englund, Aleksandra Turkiewicz, Mika Paavola, Antti Malmivaara, Ari Itälä, Antti Joukainen, Heikki Nurmi, Pirjo Toivonen, Simo Taimela, Teppo L N Järvinen

In patients with a degenerative tear of the medial meniscus, recent meta-analyses and systematic reviews have shown no treatment benefit of arthroscopic partial meniscectomy (APM) over conservative treatment or placebo surgery. Yet, advocates of APM still argue that APM is cost effective. Giving advocates of APM their due, we note that there is evidence from the treatment of other musculoskeletal complaints to suggest that a treatment may prove cost effective even in the absence of improvements in efficacy outcomes, as it may lead to other benefits, such as diminished productivity loss and reduced costs, and so the question of cost effectiveness needs to be answered for APM.

中文翻译:


与安慰剂手术相比,关节镜下部分半月板切除术治疗退行性半月板撕裂的成本效益不高:基于 FIDELITY 试验数据的经济评估。



对于内侧半月板退行性撕裂的患者,最近的荟萃分析和系统评价表明,关节镜部分半月板切除术(APM)与保守治疗或安慰剂手术相比没有治疗益处。然而,APM 的支持者仍然认为 APM 具有成本效益。为了给予 APM 的支持者应得的支持,我们注意到,来自其他肌肉骨骼疾病治疗的证据表明,即使在疗效结果没有改善的情况下,治疗也可能被证明具有成本效益,因为它可能会带来其他好处,例如减少生产力损失和成本降低,因此APM需要回答成本效益的问题。
更新日期:2024-05-07
down
wechat
bug